Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Stern

Showing results (511-520 of 659) with videos related to

Pageof 66
Sort By:
International Journal of Colorectal Disease|May 31, 2012
Genetic variation in insulin pathway genes and distal colorectal adenoma riskA Joan Levine, Ugonna Ihenacho, Won Lee, et al.
JNCI Cancer Spectrum|January 14, 2021
Presentation, Management, and Outcomes Across the Rural-Urban Continuum for Hepatocellular CarcinomaKali Zhou, Trevor A Pickering, Christina S Gainey, et al.
The Journal of Clinical Investigation|April 1, 1976
Purine nucleoside metabolism in the erythrocytes of patients with adenosine deaminase deficiency and severe combined immunodeficiencyR P Agarwal, G W Crabtree, R E Parks, et al.
Blood|March 1, 1992
Recombinant human granulocyte-macrophage colony-stimulating factor accelerates neutrophil and monocyte recovery after allogeneic T-cell-depleted bone marrow transplantationT De Witte, A Gratwohl, N Van Der Lely, et al.
Cancer Medicine|October 31, 2014
Tobacco smoking, polymorphisms in carcinogen metabolism enzyme genes, and risk of localized and advanced prostate cancer: results from the California Collaborative Prostate Cancer StudyAhva Shahabi, Román Corral, Chelsea Catsburg, et al.
Leukemia & Lymphoma|December 8, 2022
A phase 1, open-label, randomized drug-drug interaction study of zanubrutinib with moderate or strong CYP3A inhibitors in patients with B-cell malignanciesBilal Tariq, Ying C Ou, Jennifer C Stern, et al.
Carcinogenesis|May 8, 2012
Genetic variation in genes involved in hormones, inflammation and energetic factors and breast cancer risk in an admixed populationMartha L Slattery, Esther M John, Gabriela Torres-Mejia, et al.
Leukemia|November 1, 1991
In vivo effect of granulocyte-macrophage colony-stimulating factor on the kinetics of human acute myeloid leukemia cellsM Aglietta, L De Felice, A Stacchini, et al.
American Journal of Public Health|July 31, 2024
Identification of Priorities for Colorectal Cancer Screening Interventions Among US Hispanic/Latino PopulationsR Blake Buchalter, Mariana C Stern, Joel Sanchez Mendez, et al.
Ejhaem|February 23, 2023
A real-world study to assess the association of cardiovascular adverse events (CVAEs) with ibrutinib as first-line (1L) treatment for patients with chronic lymphocytic leukaemia (CLL) in the United StatesAnthony Mato, Boxiong Tang, Soraya Azmi, et al.
Pageof 66

Showing results (511-520 of 659) with videos related to

Sort By:
Pageof 66
International Journal of Colorectal Disease|May 31, 2012
Genetic variation in insulin pathway genes and distal colorectal adenoma riskA Joan Levine, Ugonna Ihenacho, Won Lee, et al.
JNCI Cancer Spectrum|January 14, 2021
Presentation, Management, and Outcomes Across the Rural-Urban Continuum for Hepatocellular CarcinomaKali Zhou, Trevor A Pickering, Christina S Gainey, et al.
The Journal of Clinical Investigation|April 1, 1976
Purine nucleoside metabolism in the erythrocytes of patients with adenosine deaminase deficiency and severe combined immunodeficiencyR P Agarwal, G W Crabtree, R E Parks, et al.
Blood|March 1, 1992
Recombinant human granulocyte-macrophage colony-stimulating factor accelerates neutrophil and monocyte recovery after allogeneic T-cell-depleted bone marrow transplantationT De Witte, A Gratwohl, N Van Der Lely, et al.
Cancer Medicine|October 31, 2014
Tobacco smoking, polymorphisms in carcinogen metabolism enzyme genes, and risk of localized and advanced prostate cancer: results from the California Collaborative Prostate Cancer StudyAhva Shahabi, Román Corral, Chelsea Catsburg, et al.
Leukemia & Lymphoma|December 8, 2022
A phase 1, open-label, randomized drug-drug interaction study of zanubrutinib with moderate or strong CYP3A inhibitors in patients with B-cell malignanciesBilal Tariq, Ying C Ou, Jennifer C Stern, et al.
Carcinogenesis|May 8, 2012
Genetic variation in genes involved in hormones, inflammation and energetic factors and breast cancer risk in an admixed populationMartha L Slattery, Esther M John, Gabriela Torres-Mejia, et al.
Leukemia|November 1, 1991
In vivo effect of granulocyte-macrophage colony-stimulating factor on the kinetics of human acute myeloid leukemia cellsM Aglietta, L De Felice, A Stacchini, et al.
American Journal of Public Health|July 31, 2024
Identification of Priorities for Colorectal Cancer Screening Interventions Among US Hispanic/Latino PopulationsR Blake Buchalter, Mariana C Stern, Joel Sanchez Mendez, et al.
Ejhaem|February 23, 2023
A real-world study to assess the association of cardiovascular adverse events (CVAEs) with ibrutinib as first-line (1L) treatment for patients with chronic lymphocytic leukaemia (CLL) in the United StatesAnthony Mato, Boxiong Tang, Soraya Azmi, et al.
Pageof 66